4 results
Primary:To determine the degree pain relief 6 months after THA/TKA when screened pre-operative for centralized pain and subsequent treated accordingly for a period of 10 weeks with Duloxetine compared to usual care (no Duloxetine) Secondary:To…
The primary objective of this study is to obtain clinical proof of principle that the addition of a PgP/BCRP inhibitor increases CNS concentrations of tyrosine kinase inhibitors by inhibition of drug efflux transporter function in the blood brain…
To determine the pharmacokinetic properties of a new elacridar formulation
This study primarily aims to test the additional effect of walking during a Virtual Reality exposure treatment (3MDR) for patients with PTSD. Next, this study aims to investigate whether addressing trauma-related avoidance during 3MDR treatment is…